[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100456388":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":34,"responsibleParty":102,"collaborators":104,"id":108,"slug":109,"hasResults":110,"nctId":111,"briefTitle":112,"officialTitle":113,"acronym":11,"eligibilityCriteria":114,"healthyVolunteers":110,"sex":115,"minAge":116,"maxAge":11,"enrollmentInfo":117,"targetDuration":11,"studyType":120,"phases":121,"briefSummary":123,"conditions":124,"keywords":126,"overallStatus":130,"whyStopped":11,"lastUpdateSubmitDate":131,"lastUpdatePostDateStruct":132,"startDateStruct":135,"completionDateStruct":137,"leadSponsor":139,"locationsCount":140},{"fullName":5,"class":6},"ANRS, Emerging Infectious Diseases","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single arm composed by 34 HIV-1 infected male subjects","OTHER",null,[13],"Other: Biopsies and bloood samplings",[15],{"type":10,"name":16,"description":17,"armGroupLabels":18,"otherNames":11},"Biopsies and bloood samplings","blood samples, rectal biopsies, nodes biopsies, cutaneous fat tissues biopsies, semen sample",[9],[20],{"name":21,"affiliation":22,"role":23},"Antoine CHERET, Pr","Centre de Diagnostic et de Thérapeutique pluridisciplinaire CHU Pointe-à-Pitre\u002FAbymes","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":11,"email":29},"Fatoumata Coulibaly","CONTACT","+331 44 23 61 10","fatoumata.coulibay@inserm.fr",{"name":31,"role":27,"phone":32,"phoneExt":11,"email":33},"Sophie LETROU","+331 40 25 65 81","sophie.letrou@aphp.fr",[35,50,63,75,84,93],{"facility":36,"status":11,"city":37,"state":11,"zip":11,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Antoine-Beclere Hospita","Clamart","France","FR",{"type":41,"coordinates":42},"Point",[43,44],2.26692,48.80299,{"lat":44,"lon":43},[47,49],{"name":48,"role":27,"phone":11,"phoneExt":11,"email":11},"Sophie ABGRALL",{"name":48,"role":23,"phone":11,"phoneExt":11,"email":11},{"facility":51,"status":11,"city":52,"state":11,"zip":11,"country":38,"countryCode":39,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Bicetre Hospital","Le Kremlin-Bicêtre",{"type":41,"coordinates":54},[55,56],2.36073,48.81471,{"lat":56,"lon":55},[59,61],{"name":60,"role":27,"phone":11,"phoneExt":11,"email":11},"Elina TEICHER",{"name":62,"role":23,"phone":11,"phoneExt":11,"email":11},"Antoine CHERET",{"facility":64,"status":11,"city":65,"state":11,"zip":11,"country":38,"countryCode":39,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Hotel Dieu Hospital","Paris",{"type":41,"coordinates":67},[68,69],2.3488,48.85341,{"lat":69,"lon":68},[72,74],{"name":73,"role":27,"phone":11,"phoneExt":11,"email":11},"Dominique SALMON-CERON",{"name":73,"role":23,"phone":11,"phoneExt":11,"email":11},{"facility":76,"status":11,"city":65,"state":11,"zip":11,"country":38,"countryCode":39,"cosmosGeoPoint":77,"geoPoint":79,"contacts":80},"Necker Hospital",{"type":41,"coordinates":78},[68,69],{"lat":69,"lon":68},[81,83],{"name":82,"role":27,"phone":11,"phoneExt":11,"email":11},"Claudine Duvivier",{"name":82,"role":23,"phone":11,"phoneExt":11,"email":11},{"facility":85,"status":11,"city":65,"state":11,"zip":11,"country":38,"countryCode":39,"cosmosGeoPoint":86,"geoPoint":88,"contacts":89},"Pitie Salpetriere Hospital",{"type":41,"coordinates":87},[68,69],{"lat":69,"lon":68},[90,92],{"name":91,"role":27,"phone":11,"phoneExt":11,"email":11},"Valérie MARTINEZ",{"name":91,"role":23,"phone":11,"phoneExt":11,"email":11},{"facility":94,"status":11,"city":65,"state":11,"zip":11,"country":38,"countryCode":39,"cosmosGeoPoint":95,"geoPoint":97,"contacts":98},"Saint Antoine Hospital",{"type":41,"coordinates":96},[68,69],{"lat":69,"lon":68},[99,101],{"name":100,"role":27,"phone":11,"phoneExt":11,"email":11},"Karine LACOMBE",{"name":100,"role":23,"phone":11,"phoneExt":11,"email":11},{"type":103,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[105],{"name":106,"class":107},"Gilead Sciences","INDUSTRY","100456388","a-study-to-determine-the-cartography-of-virologic-reservoir-related-to-antiretroviral-concentrations-in-hiv-1-chronic-patients-treated-by-a-first-line-treatment-containing-bictgravir-emtricitabine-and-tnofovir-alafnamide-100456388",false,"NCT05222945","A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide","ANRS EP69 BICTEVOIR : A Prospective Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide","Inclusion Criteria:\n\n* Male HIV-1 infected subjects\n* Age \\> or = 18 years old\n* Currently receiving as first line a stable ARV regimen containing bictegravir (at 50 mg once a day) and two nucleoside reverse transcriptase inhibitors, tenofovir alafenamide\u002Femtricitabine (Biktarvy)\n* HIV RNA \\\u003C50 Cp\u002FmL, undetectable 6 months after treatment initiation and confirmed and 12 months after treatment initiation.\n* Normal laboratory value of TP and TCA and platelets numbers at screening\n* Written and informed consent signed by the person and the investigator (no later than the day of pre-inclusion and prior to any examination realized in the frame of the research \u002F study \u002F trial) (article L1122-1-1 of the Public Health Code)\n* Person affiliated or beneficiary of a social security scheme (article L1121-11 of the Public Health Code) (State Medical Aid or AME is not a social security scheme)\n\nExclusion Criteria:\n\n* Single HIV-2 infection\n* Biopsies contraindication, taking anticoagulant and antiplatelet drugs are not allowed\n* Haemophilia\n* Symptomatic sexually transmitted infection\n* Being under guardianship or trusteeship mandate for future protection\n* Participate to another research involving human person, categories 1 or 2,\n* Associated treatments : carbamazepine, oxcarbazepine, phenytoin, phenobarbital, rifampicin, St. John's Wort.","MALE","18 Years",{"count":118,"type":119},34,"ESTIMATED","INTERVENTIONAL",[122],"NA","The main objective of the study is to evaluate the diffusion of bictegravir and associated backbone (tenofovir alafenamide and emtricitabine) in HIV-1 chronic patients in the main putative reservoirs, namely inguinal lymph nodes, rectal, fat tissues and sperm.",[125],"HIV-1-infection",[127,128,129],"Viral cartography","Viral reservoir","Antiretroviral treatments diffusion","NOT_YET_RECRUITING","2025-02-03",{"date":133,"type":134},"2025-02-05","ACTUAL",{"date":136,"type":119},"2025-04-01",{"date":138,"type":119},"2025-10-31",{"name":5,"class":6},6]